EdnaMancillaMD

Pediatric Endocrinology • Philadelphia, PA

Professor of Clinical Pediatrics, Perelman School of Medicine

Overview of Dr. Mancilla

Dr. Edna Mancilla is a pediatric endocrinologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Children's Hospital of Philadelphia, Hospital of the University of Pennsylvania, and Pennsylvania Hospital. She received her medical degree from University of Chile and has been in practice 30 years. Dr. Mancilla accepts several types of health insurance, listed below. She is one of 62 doctors at Children's Hospital of Philadelphia and one of 34 doctors at Hospital of the University of Pennsylvania who specialize in Pediatric Endocrinology. She has more than 20 publications and over 500 citings.

Office
3500 Civic Center Blvd
Children's Hospital Of Philadelphia - Endocrinology
Philadelphia, PA 19104
Book by Phone+1(267) 369-9608

Fax+1 215-590-3053

Education & Training

UPMC Medical EducationFellowship, Pediatric Endocrinology, 1993 - 1994
MedStar Health/Georgetown University HospitalResidency, Pediatrics, 1991 - 1993
NYU Grossman School of MedicineInternship, Pediatrics, 1990 - 1991
University of ChileClass of 1987

Certifications & Licensure

PA State Medical License 1993 - 2024
NJ State Medical License 2009 - 2019
DC State Medical License 1995 - 1998
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth with Primary and Secondary Skeletal Fragility.
Ashley J Stoffers, Edna E Mancilla, Michael A Levine, Michael Mayer, Heather M Monk
The Journal of Clinical Endocrinology and Metabolism. 2024-09-26
1 citations
Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to...
Meghan Craven, Mary Ellen Vajravelu, Karuna V Shekdar, Michael A Levine, Steven Mumm
Bone. 2023-05-01
20 citations
Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).
Robert J Pignolo, Edward C Hsiao, Mona Al Mukaddam, Geneviève Baujat, Staffan K Berglund
Journal of Bone and Mineral Research. 2023-03-01

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AmeriHealth Direct POS
AmeriHealth Direct POS Value Network
Amerihealth HMO
AmeriHealth HMO Value Network
AmeriHealth PPO
AmeriHealth PPO Value Network
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
Coventry Missouri - HMO/POS
First Health PPO
GHI PPO
Great West PPO
HealthAmerica HealthAssurance PPO
HIP of New York - Select PPO
Horizon BCBS Direct Access
Horizon BCBS HMO
Horizon BCBS POS
Horizon BCBS PPO
Humana ChoiceCare Network PPO
IBC Keystone HMO / POS
IBC Personal Choice PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment